References
- Westby M, Benson M, Gibson P. Anticholinergic agents for chronic asthma in adults. Cochrane Database Syst Rev 2004; 3:CD003269.
- Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 2005; 60:740–746.
- Iwamota H, Yokoyama A, Shiota N, Shoda H, Haruta Y, Hattori N, Kohno N. Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype. Eur Respir J 2008; 31:1379–1380.
- Park HW, Yang MS, Park CS, Kim TB, Moon HB, Min KU, Kim YY, Cho SH. Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB2 as a potential marker to predict response. Allergy 2009; 64:778–783.
- Ogale SS, Lee TA, Au DH, Kim TB, Moon HB, Min KU, Kim YY, Cho SH. Cardiovascular events associated with ipratropium bromide in COPD. Chest 2010; 137(1):13–19.
- Camargo CA, Rachelefsky G, Schatz M. Managing asthma exacerbations in the emergency department. Summary of the National Asthma Education and Prevention Program Expert Panel Report 3 Guidelines for the Management of Asthma Exacerbations. Proc Am Thorac Soc 2009; 76:357–366.
- Schatz M, Kazzi AA, Brenner B, Camargo CA Jr, Corbridge T, Krishnan JA, Nowak R, Rachelefsky G. The Joint Task Force report: supplemental recommendation for the management and follow-up of asthma exacerbations. Proc Am Thorac Soc 2009; 6:353–356.
- Van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 2007; 16:219–242.
- Donahue JG, Weiss ST, Livingston JM, Camargo CA Jr, Corbridge T, Krishnan JA, Nowak R, Rachelefsky G. Inhaled steroids and the risk of hospitalization for asthma. J Am Med Assoc 1997; 277:887–891.
- Anis AH, Lynd LD, Wang X, et al. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. CMAJ 2001; 164:625–631.
- Siossa S, Ermst P, Kezouh A. Regular use of inhaled corticosteroids and the long term prevention of hospitalization for asthma. Thorax 2002; 57:880–884.
- Garrett J, Kolbe J, Richards G, Whitlock T, Rea H. Major reduction in asthma morbidity and continued reduction in asthma mortality in New Zealand: what lessons have been learned? Thorax 1995; 50:303–311.
- Sly RM. Changing asthma mortality and sales of inhaled bronchodilators and anti-asthmatic drugs. Ann Allergy 1994; l73:439–443.
- Lanes SF, Garcia Rodriguez LA, Huerta C. Respiratory medications and risk of asthma death. Thorax 2002; 57:683–386.
- Goldman M, Rachmiel M, Gendler L, Katz Y. Decrease in asthma mortality rate in Israel from 1991–1995: is it related to increased use of inhaled corticosteroids? J Allergy Clin Immunol 2000; 105:71–74.
- GINA (Global Initiative for Asthma). Global Strategy for Asthma Management and Prevention. Bethesda, MD: National Institutes of Health, National Heart Lung and Blood Institute, 2008.
- Weber EJ, Silverman RA, Callaham ML, Pollack CV, Woodruff PG, Clark S, Camargo CA Jr. A prospective multicenter study of factors associated with hospital admission among adults with acute asthma. Am J Med 2002; 113:371–378.
- Lynd LD, Guh DP, Pare PD, Anis AH. Patterns of inhaled asthma medication use: a 3-year longitudinal analysis of prescription claims data from British Columbia, Canada. Chest 2002; 122:1973–1981.
- Waisel Y, Ganor E, Glikman M, Epstein V, Brenner S. Seasonal distribution of airborne pollen in the coastal plain of Israel. Aerobiologia 1997; 13:127–134.
- Menckeberg TT, Belitser SV, Bouvy ML, Bracke M, Lammers JW, Raaijmakers JA, Leufkens HG. Distinguishing patterns in the dynamics of long-term medication use by Markov analysis: beyond persistence. BMC Health Serv Res 2007; 7:106–114.
- Moorman JE, Zahran H, Truman BI, Molla MT. Current asthma prevalence – United States, 2006–2008. Center for Disease Control and Prevention: Morbidity and Mortality Weekly Report; 14 January 2011: 60:84–86.